Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Philip Austin - aVenture Research

Philip Austin

AddedMar 31, 2024

UpdatedOct 16, 2026

Philip Austin

Philip Austin

Co-Founder, Anterra Capital

Philip Austin's Career

Anterra Capital

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmAmsterdam, North Holland, NL

Co-Founder

Animol Discovery

Series B$40MBoston, MA, US

Founder

Invetx

Series B$85.8MBoston, MA, US

Board Member· Board

Native Microbials

$1.4MSan Diego, CA, US

Board Member· Board

AgriMetis

Series B$32MLutherville-Timonium, MD, US

Board Member· Board

Vestaron

Series D$345.9MKalamazoo, MI, US

Board Member· Board

People Similar to Philip Austin

Keith GillardBoard Member · NewLeaf Symbiotics

Leadership at Anterra Capital

Adam AndersCo-Founder

Maarten GoossensCo-Founder

Similar to Anterra Capital

Aliment CapitalSanta Monica, CA, USest. 2014Aliment CapitalSanta Monica, CA, US · est. 2014

Pontifax Agtech: A global investment firm specializing in agtech sectors, serving clients worldwide.

Investment Firm12

Astanor VenturesLuxembourg, BEest. 2017Astanor VenturesLuxembourg, BE · est. 2017

Astanor Ventures: Impact investor backing disruptive agrifood solutions for systemic change.

Investment Firm33

Investeco CapitalToronto, Ontario, CAest. 2003Investeco CapitalToronto, Ontario, CA · est. 2003

InvestEco: Investing in North American food and agriculture for health, sustainability, and strong returns.

Investment Firm13

Harvest Ridge CapitalNew York, USest. 2021Harvest Ridge CapitalNew York, US · est. 2021

Early-stage capital provider for innovators revolutionizing the food industry.

Investment Firm2

Similar to Animol Discovery

AMPLY DiscoveryBelfast, Belfast District, GBDrug Discoveryest. 2021AMPLY DiscoveryBelfast, Belfast District, GB · est. 2021

AMPLY Discovery: Innovating anti-infective health solutions for human and animal wellbeing.

AnagenexSan Francisco, CA, USDrug Discoveryest. 2020AnagenexSan Francisco, CA, US · est. 2020

Anagenex: A seed-stage biotech firm innovating drug discovery for challenging targets.

Series A · $37.2M27

Animal Life SciencesHouston, TX, USNutrition, Pharmaceuticalsest. 2019Animal Life SciencesHouston, TX, US · est. 2019

Animal Life Sciences, a Texas-based company, develops nutritional and pharmaceutical treatments for pets using human cancer technologies.

Seed · $198.8k2

Animal BiosciencesBoston, MA, USPet Health, Supplementsest. 2017Animal BiosciencesBoston, MA, US · est. 2017

Developing innovative bioscience products for animal health and wellness.

Seed · $2.3M30

Leadership at Invetx

Juergen HornFounder

Similar to Invetx

AniviveLong Beach, CA, USPharmaceuticals, Therapeuticsest. 2015AniviveLong Beach, CA, US · est. 2015

Anivive: A pharmaceutical company revolutionizing pet healthcare through innovative therapeutics.

Public · $44.8M34

Rex Animal HealthKansas City, KS, USData Analyticsest. 2013Rex Animal HealthKansas City, KS, US · est. 2013

Data-driven company transforming animal health through innovative big data solutions.

Animol DiscoveryBoston, MA, USVeterinary Drugsest. 2019Animol DiscoveryBoston, MA, US · est. 2019

Animol: Innovating veterinary drug discovery with a team of experts and a powerful tech platform.

Series B · $40M18

VetigenicsPhiladelphia, PA, USAntibody Therapiesest. 2017VetigenicsPhiladelphia, PA, US · est. 2017

Vetigenics develops innovative antibody therapies for cancer and chronic diseases in pets.

Pre-Seed · $550k9

Leadership at Native Microbials

Mallory EmbreeBoard Member

Karsten ZenglerCo-Founder

Similar to Native Microbials

AnimalBiomeOakland, CA, USPet Healthest. 2016AnimalBiomeOakland, CA, US · est. 2016

AnimalBiome: Enhancing pet health through microbiome assessments and innovative digestive treatments.

Series A · $12.3M64

BiomEditFishers, IN, USBioactives, Probioticsest. 2022BiomEditFishers, IN, US · est. 2022

BiomEdit, an Indiana-based medical firm, innovates in probiotics and microbial medicines for unmet animal health needs.

Series A · $44.5M36

Ascus BiosciencesSan Diego, CA, USMicrobial Productsest. 2015Ascus BiosciencesSan Diego, CA, US · est. 2015

Ascus Biosciences, a San Diego-based firm, pioneers in developing next-gen microbial products since 2015.

Series B · $51M30

BactanaFarmington, CT, USAnimal Healthest. 2017BactanaFarmington, CT, US · est. 2017

Bactana Corp: A global leader in developing safe, sustainable alternatives to antibiotics in animal health.

Series A · $2M5

Leadership at AgriMetis

Philip GoeletBoard Member

Steven TuttleBoard Member

John AtkinBoard Member

Simon AsplandCo-Founder

Brian GreenCo-Founder

Similar to AgriMetis

CropsolutionMorrisville, NC, USAgrochemicals, Crop Protectionest. 2001CropsolutionMorrisville, NC, US · est. 2001

Innovative medical and agrochemical solutions from Morrisville, NC.

Series C · $9.3M50

Leadership at Vestaron

Susan AltschullerBoard Member

Jim CollinsBoard Member

Ron MeeusenBoard Member

Adam WieschhausBoard Member

Glenn KingFounder

Similar to Vestaron

LepidextLexington, KY, USPest Controlest. 2015LepidextLexington, KY, US · est. 2015

Lepidext: Enhancing agricultural prosperity through species-specific bio-pesticides for pest management.

Pre-Seed · $791.4k2

5MetisDurham, NC, USCrop Protectionest. 2021

5MetisDurham, NC, US · est. 2021

5Metis: A pioneering crop health discovery firm, merging boron-based molecules and synthetic biology.

Series A · $10M14

AgrynexIthaca, NY, USBiopesticides, Crop Protectionest. 2015AgrynexIthaca, NY, US · est. 2015

Agrynex: Providing biocidal enzymes for crop protection against soil-borne diseases.

Crop EnhancementSan Jose, CA, USCrop Protectionest. 2011Crop EnhancementSan Jose, CA, US · est. 2011

Crop Enhancement: Boosting crop yields with sustainable, eco-friendly agrochemical solutions.

Series B · $16.5M31

ProviviSanta Monica, CA, USInsect Control, Technologyest. 2013

ProviviSanta Monica, CA, US · est. 2013

US-based Provivi pioneers scalable, safer insect control tech for improved global quality of life.

Series D · $191.7M155

VeserisAustin, TX, USPest Control, Productsest. 2020VeserisAustin, TX, US · est. 2020

Veseris: Comprehensive provider of products and services for diverse environmental science markets.

InsectaPelWellford, SC, USInsect RepellentsInsectaPelWellford, SC, US

InsectaPel offers cost-effective, sustainable, biobased insect repellents for textiles, transforming the market.